Type 2 & other diabetes

Plasma Sphingolipids in Relation to Glycemia and Glucose Tolerance in People Without Diabetes

J Clin Endocrinol MetabPublished Cross-sectional study

Authors' conclusion

Circulating levels of major sphingolipid species are significantly associated with glycemia and glucose tolerance, indicating a possible link between sphingolipid metabolism and glucoregulation in people without diabetes.

Study context

Population
Adults without diabetes from the Pathobiology of Prediabetes in a Biracial Cohort study and the Diabetes Prevention Program; 63% female, 48% Black, mean age 45.5 ± 9.84 years, body mass index (BMI) 32.4 ± 7.24 kg/m²Diabetes Prevention Program 280
Exposure
Plasma sphingolipids across glucose tolerance categories
Outcome
Association of plasma sphingolipids with FPG, 2hPG and glucose tolerance category
Follow-up
Baseline
Methodological detailsbaseline specimens from two cohorts (POP-ABC and DPP), liquid chromatography tandem mass spectrometry
  • Baseline specimens from two cohorts (POP-ABC and DPP)
  • Liquid chromatography tandem mass spectrometry

Main finding

As reported in the abstract

Ceramides, sphingomyelins and sphingosine increased progressively across NFG-NGT, isolated impaired glucose tolerance (IGT) and IFG-IGT; the opposite for monohexosyl ceramides, lactosyl ceramides and sphingosine-1 phosphate

ANOVA P < .0001

Observational data: associations, not effects.

Original publication

Plasma Sphingolipids in Relation to Glycemia and Glucose Tolerance in People Without Diabetes. J Clin Endocrinol Metab. Published 26 June 2025. doi:10.1210/clinem/dgaf378

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.